Metastatic Colorectal Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class (Anti-EGFR (Epidermal Growth Factor Receptor) Inhibitors, Anti-VEGF (Vascular Endothelial Growth Factor) Therapies, Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapies, Immune Checkpoint Inhibitors, Others), By Distribution Channel (Hospital Pharm